Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy

Neurol Neuroimmunol Neuroinflamm. 2021 Nov 11;9(1):e1111. doi: 10.1212/NXI.0000000000001111. Print 2022 Jan.

Abstract

Background and objectives: The mechanisms of pain in patients with diabetic polyneuropathy are unknown. Studies have suggested a role of inflammation and increased neuropeptides peripherally in pain generation. This study examined the possible skin markers of painful diabetic polyneuropathy (P-DPN): macrophages, substance P (SP), and calcitonin gene-related peptide (CGRP).

Methods: The participants were included from a large Danish cross-sectional clinical study of type 2 diabetes. We diagnosed definite diabetic polyneuropathy using the Toronto criteria and used the Neuropathic Pain Special Interest Group classification for defining P-DPN. We included 60 skin biopsies from patients with diabetic polyneuropathy-30 with P-DPN and 30 with nonpainful diabetic polyneuropathy (NP-DPN)-and 30 biopsies from healthy controls of similar age and sex. The biopsies were stained using PGP 9.5, IbA1, and SP and CGRP primary markers.

Results: There was increased macrophage density in patients with P-DPN (8.0%) compared with that in patients with NP-DPN (5.1%, p < 0.001), and there was increased macrophage density in patients with NP-DPN (5.1%) compared with that in healthy controls (3.1%, p < 0.001). When controlling for neuropathy severity, body mass index, age, and sex, there was still a difference in macrophage density between patients with P-DPN and patients with NP-DPN. Patients with P-DPN had higher median nerve fiber length density (274.5 and 155 mm-2 for SP and CGRP, respectively) compared with patients with NP-DPN (176 and 121 mm-2 for SP and CGRP, respectively, p = 0.009 and 0.04) and healthy controls (185.5 and 121.5 mm-2 for SP and CGRP, respectively), whereas there was no difference between patients with NP-DPN and controls without diabetes (p = 0.64 and 0.49, respectively). The difference between P-DPN and NP-DPN for SP and CGRP was significant only in female patients, although a trend was seen in male patients.

Discussion: The findings point to a possible involvement of the innate immune system in the pathogenesis of neuropathic pain in patients with DPN, although markers of activated macrophages were not measured in this study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers
  • Biopsy
  • Calcitonin Gene-Related Peptide / metabolism
  • Cross-Sectional Studies
  • Diabetic Neuropathies* / complications
  • Diabetic Neuropathies* / immunology
  • Diabetic Neuropathies* / metabolism
  • Diabetic Neuropathies* / pathology
  • Female
  • Humans
  • Macrophages*
  • Male
  • Middle Aged
  • Nerve Fibers* / metabolism
  • Nerve Fibers* / pathology
  • Neuralgia* / etiology
  • Neuralgia* / immunology
  • Neuralgia* / metabolism
  • Neuralgia* / pathology
  • Skin* / immunology
  • Skin* / metabolism
  • Skin* / pathology
  • Substance P / metabolism

Substances

  • Biomarkers
  • Substance P
  • Calcitonin Gene-Related Peptide